Nuvation Bio Enters Material Definitive Agreement
Ticker: NUVB · Form: 8-K · Filed: Mar 25, 2025 · CIK: 1811063
Sentiment: neutral
Topics: material-definitive-agreement, corporate-action
TL;DR
Nuvation Bio signed a big deal on 3/21. Details to follow.
AI Summary
Nuvation Bio Inc. entered into a material definitive agreement on March 21, 2025. The company, formerly known as Panacea Acquisition Corp., is incorporated in Delaware and operates in the pharmaceutical preparations sector.
Why It Matters
This filing indicates a significant development or transaction for Nuvation Bio Inc., potentially impacting its business operations, financial standing, or strategic direction.
Risk Assessment
Risk Level: medium — Entering into a material definitive agreement can introduce new risks or opportunities, the nature and impact of which are not yet fully detailed in this initial filing.
Key Numbers
- 001-39351 — SEC File Number (Identifies Nuvation Bio's filing with the SEC)
- 85-0862255 — EIN (Employer Identification Number for Nuvation Bio Inc.)
Key Players & Entities
- Nuvation Bio Inc. (company) — Registrant
- Panacea Acquisition Corp. (company) — Former company name
- March 21, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- 2834 (sic_code) — Standard Industrial Classification for Pharmaceutical Preparations
FAQ
What type of material definitive agreement did Nuvation Bio Inc. enter into?
The filing states that the company entered into a 'Material Definitive Agreement' but does not specify the nature of the agreement in this section.
When was the earliest event reported in this 8-K filing?
The earliest event reported is dated March 21, 2025.
What was Nuvation Bio Inc.'s former company name?
Nuvation Bio Inc.'s former company name was Panacea Acquisition Corp.
In which state is Nuvation Bio Inc. incorporated?
Nuvation Bio Inc. is incorporated in Delaware.
What is Nuvation Bio Inc.'s Standard Industrial Classification (SIC) code?
Nuvation Bio Inc.'s SIC code is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 25, 2025 regarding Nuvation Bio Inc. (NUVB).